Mycoplasma pneumoniae pneumonia in children
Conditions
Interventions
Experimental group:Qingjin Tongluo Formula Combined with Azithromycin
Control group:Qingjin Tongluo Formula Simulator Combined with Azithromycin
Sponsors
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
1 Years to 12 Years
Inclusion criteria
Inclusion criteria: Only those who meet all the following criteria can be selected: (1) Those who meet the Western medical diagnostic criteria for Mycoplasma pneumoniae pneumonia in children; (2) Those who meet the diagnostic criteria for traditional Chinese medicine syndrome differentiation; (3) Age range from 1 to 12 years old; (4) Within 48 hours of diagnosis of pneumonia; (5) Agree to cooperate with medication and undergo evaluation according to the requirements of the experimental protocol; (6) Must obtain the informed consent of the legal guardian of the subject and voluntarily sign the informed consent form; When the subject is able to make a decision to participate in a clinical trial, they must also obtain their own consent.
Exclusion criteria
Exclusion criteria: Those who meet any of the following criteria need to be excluded: (1) Clinically diagnosed with severe pneumonia; (2) Patients with concurrent episodes of respiratory diseases other than pneumonia; (3) Concomitant severe primary diseases such as heart, liver, kidney, digestive and hematopoietic systems; (4) Those who are clearly allergic to the experimental drug or its formulation components, or have allergic constitution; (5) Those who have participated in clinical trials within 3 months; (6) Researchers believe that individuals should not be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total response rate of the disease;Time window for the efficacy of pediatric pneumonia; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome effect;Single symptom curative effect;Combined with medication use;Conversion rate;Serum inflammatory response related factors;Serum T cell subpopulations; | — |
Countries
China
Contacts
Public ContactXuefeng Wang
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Outcome results
None listed